SERA

Sera Prognostics, Inc.

8.13 USD
+0.15 (+1.88%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sera Prognostics, Inc. stock is down -1.57% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 June’s closed higher than May.

About Sera Prognostics, Inc.

Sera Prognostics, Inc. develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.